Company: FFWM
Filing Date: 2025-11-03
Form Type: SCHEDULE 13D
Source: 0001999371-25-016764
Chunk: 2

Company: First Foundation Inc.
Filing Date: 2025-11-03
Form: SCHEDULE 13D
Chunk 2
---
 A copy of the form of Amendment No. 2 is included as Exhibit J to the Merger Agreement, a copy of which is filed as Exhibit 2.1 in the Issuer's Form 8-K filed with the SEC on October 30, 2025, and is incorporated herein by reference. The foregoing summary of the PTA is qualified in its entirety by the full text of the PTA, a copy of which is included as Exhibit I to the Merger Agreement, a copy of which is filed as Exhibit 2.1 in the Issuer's Form 8-K filed with the SEC on October 30, 2025, and is incorporated herein by reference. A copy of the PTA is filed as Exhibit 4 hereto.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 On October 27, 2025, the Issuer and the Accounts entered into a Warrant Exercise and Termination Agreement (the "WETA"), pursuant to which, in connection with the Transactions, and conditioned upon the consummation of the Merger, the Accounts will be deemed to have exercised the Series C Warrants held by them immediately prior to the Effective Time in full on a cashless basis, in accordance with the terms of the Series C Warrant and the WETA, in exchange for the applicable issued Series C Non-Voting Common Equivalent Stock. Additionally, at or immediately prior to the Effective Time, the Accounts will receive the Warrant Termination Consideration (as defined in the WETA) for the exercise of the Series C Warrants. The foregoing summary of the WETA is qualified in its entirety by the full text of the WETA, a copy of which is included as Exhibit G to the Merger Agreement, a copy of which is filed as Exhibit 2.1 in the Issuer's Form 8-K filed with the SEC on October 30, 2025, and is incorporated herein by reference. A copy of the WETA is filed as Exhibit 5 hereto.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 The Reporting Persons may, from time to time, engage in discussions with members of management and the Board, other current or prospective shareholders, industry analysts, existing or potential strategic partners, acquirers or competitors, investment professionals, financing sources and other third parties regarding the foregoing and a broad range of matters relating to the Issuer, including, among other things, the Issuer's business, operations, management, organizational documents, ownership, capital or corporate structure, dividend policy, corporate governance,